China has reported 460 human infections with the H7N9 avian flu virus since last October, more than in any year since the novel virus emerged there in 2013, the Centers for Disease Control and Prevention announced last week. During the prior years, 88% of patients developed pneumonia, 68% were admitted to an intensive care unit and 41% died. H7N9 viruses have not been detected in people or birds in the United States and currently pose low risk to public health, CDC said. However, the agency is using reverse genetics to prepare a candidate vaccine virus and will continue to track the virus’ potential for pandemic risk. For more on the H7N9 virus, including guidance for U.S. clinicians, visit www.cdc.gov.
The Centers for Medicare & Medicaid Services has extended the deadline for submitting third-quarter data to the Post-Acute Care Quality Reporting Program.
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Hospitals and clinicians are seeing fewer flu patients this season than in other recent years, the Centers for Disease Control and Prevention reports.
Insights and Analysis
Share how your organization is working to improve health equity – apply for the AHA Equity of Care Award Applications for the 2019 AHA Equity of Care Award are due by Feb. 19
Please consider applying for the award and sharing how your organization is improving health equity and value.
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or…